| Date | Time | Source | Headline | Symbol | Company |
| 09/14/2024 | 3:15AM | Alliance News |  US President Biden, UK PM Starmer put off Ukraine missiles decision | | |
| 09/14/2024 | 3:15AM | Business Wire | KEYTRUDA® (pembrolizumab) Plus Trastuzumab and Chemotherapy Significantly Improved Overall Survival (OS) Versus Trastuzumab and Chemotherapy Alone in First-Line Treatment of Patients With HER2-Positive Advanced Gastric or GEJ Adenocarcinoma | NYSE:MRK | Merck and Co Inc |
| 09/14/2024 | 3:14AM | Alliance News | Harris, Trump campaign in US battlegrounds as migrant row intensifies | | |
| 09/14/2024 | 3:10AM | Alliance News | TOP NEWS: China retail sales, industrial production slow in August | | |
| 09/14/2024 | 3:10AM | PR Newswire (US) | RYBREVANT® (amivantamab-vmjw) plus chemotherapy shows positive overall survival trend versus chemotherapy in patients with previously treated EGFR-mutated lung cancer | NYSE:JNJ | Johnson and Johnson |
| 09/14/2024 | 3:10AM | GlobeNewswire Inc. | Acrivon Therapeutics Reports Positive Endometrial Cancer Data from Ongoing ACR-368 Registrational Intent Phase 2 Study at ESMO, Advancement of ACR-2316 into Clinic Ahead of Timelines, and Progress on its AP3 Interactome for Proprietary Data Analysis | NASDAQ:ACRV | Acrivon Therapeutics Inc |
| 09/14/2024 | 3:09AM | Alliance News | China says German ships in Taiwan Strait "increase security risks" | | |
| 09/14/2024 | 3:09AM | Alliance News | UK PM Starmer says serious and ambitious about reset with EU | | |
| 09/14/2024 | 3:05AM | Business Wire | Positive Pooled Data from Nuvation Bio’s TRUST-I and TRUST-II Studies Highlight Taletrectinib’s Best-in-Class Potential for Patients with Advanced ROS1-positive NSCLC, Supporting Planned New Drug Application Submission in the Fourth Quarter of 2024 | NYSE:NUVB | Panacea Acquisition Corp |
| 09/14/2024 | 3:05AM | GlobeNewswire Inc. | Transgene and BioInvent’s Oncolytic Virus BT-001 Shows Promising Antitumor Activity in Ongoing Phase I/IIa Trial in Solid Tumors that Failed Previous Treatments | EU:TNG | Transgene SA |
| 09/14/2024 | 3:01AM | GlobeNewswire Inc. | NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024 | NASDAQ:NCNA | NuCana PLC |
| 09/14/2024 | 3:00AM | GlobeNewswire Inc. | Immunocore presents Phase 1 data of brenetafusp, an ImmTAC bispecific targeting PRAME, in patients with ovarian cancer | NASDAQ:IMCR | Immunocore Holdings PLC |
| 09/14/2024 | 3:00AM | GlobeNewswire Inc. | Sutro Biopharma Announces Updated Data from Phase 1b Study of Luvelta in Combination with Bevacizumab at ESMO 2024 | NASDAQ:STRO | Sutro Biopharma Inc |
| 09/14/2024 | 3:00AM | GlobeNewswire Inc. | Avacta Reports Updated Phase 1 Clinical Data of AVA6000 at the European Society for Medical Oncology (ESMO) Congress Demonstrating Multiple Ongoing, Durable Responses in Solid Tumors | LSE:AVCT | Avacta Group Plc |
| 09/14/2024 | 3:00AM | Business Wire | Bicycle Therapeutics Presents Updated Clinical Results Across Oncology Pipeline at ESMO Congress 2024 | NASDAQ:BCYC | Bicycle Therapeutics PLC |
| 09/14/2024 | 2:39AM | Business Wire | Deuxième conférence sur l'échange de cultures agricoles et l'apprentissage mutuel dans le monde « FROM ZIQUEJIE TERRACES TO THE WORLD » | | |
| 09/14/2024 | 2:30AM | GlobeNewswire Inc. | IO Biotech Announces Positive Results from Phase 2 Trial of IO102-IO103 in the First-line Treatment of Advanced Head and Neck Cancer | NASDAQ:IOBT | IO Biotech Inc |
| 09/14/2024 | 2:30AM | GlobeNewswire Inc. | iTeos Announces Clinically Meaningful Objective Response Rate Observed at Every Dose in Follow-up Interim Analysis of GALAXIES Lung-201 Study of Belrestotug + Dostarlimab in First-Line, PD-L1 High Non-Small Cell Lung Cancer Patients | NASDAQ:ITOS | iTeos Therapeutics Inc |
| 09/14/2024 | 2:05AM | Business Wire | SCF übernimmt Newpark Fluids Systems | NYSE:NR | Newpark Resources Inc |
| 09/14/2024 | 2:05AM | Business Wire | SCF acquiert Newpark Fluids Systems | NYSE:NR | Newpark Resources Inc |
| 09/14/2024 | 1:57AM | PR Newswire (US) | TIME, Statista Name Three SM companies Among World's Best Companies | | |
| 09/14/2024 | 1:34AM | PR Newswire (US) | Unveil Delightful Wine and Champagne Gifts To Share This Thanksgiving | | |
| 09/14/2024 | 1:07AM | PR Newswire (US) | Xinhua Silk Road: China's services trade fair promotes shared prosperity among global businesses | | |
| 09/14/2024 | 1:07AM | PR Newswire (Canada) | Xinhua Silk Road: China's services trade fair promotes shared prosperity among global businesses | | |
| 09/14/2024 | 1:00AM | PR Newswire (US) | Posh Multiverse Makes History as the First Avatar Signed by a Professional Modeling Agency, Set to Debut at Fashion Week San Diego 2024 Fall Fashion Show | | |
| 09/14/2024 | 12:46AM | PR Newswire (US) | MSquare Technology Showcases Leadership in IP and Chiplet Innovation at the AI Hardware & Edge AI Summit | | |
| 09/14/2024 | 12:27AM | PR Newswire (US) | Xinhua Silk Road: China's services trade fair promotes shared prosperity among global businesses | | |
| 09/14/2024 | 12:27AM | PR Newswire (Canada) | Xinhua Silk Road: China's services trade fair promotes shared prosperity among global businesses | | |
| 09/14/2024 | 12:21AM | PR Newswire (US) | NiceTop™️ Unveils New Hair Growth Supplement Amid Product Line Expansion | | |
| 09/13/2024 | 11:19PM | PR Newswire (Canada) | XCMG Unveils Major Lineup for MinExpo 2024, Showcasing Advanced Mining Solutions | | |